The Centers for Disease Control and Prevention announced Tuesday that a person has been diagnosed with Ebola in the United States. The market reacted accordingly.
Here are some examples of those who might profit from Ebola’s continued spread, more than six months into the deadliest outbreak in history.
The most striking monetary effect of the CDC’s announcement was encapsulated in this headline from USA Today: “Ebola stocks soar after infection hits U.S.”
Yes, the makers of experimental drugs that have a shot at becoming the first confirmed Ebola treatment fared well in the markets after the Ebola-in-the-U.S. news broke.